h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
TRNDi003-A
Registration Summary
:
A
P
E
C
iPSC HT215A
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
TRNDi003-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
TRNDi003-A (RRID:CVCL_UL12)
Alternative name(s)
iPSC HT215A
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
27th March 2019
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
NIH/NCATS-TRND Branch (TRND)
External Databases
Cellosaurus
CVCL_UL12
Wikidata
Q98133577
General Information
Publications
Li R et al. Generation of an induced pluripotent stem cell line (TRNDi003-A) from a Noonan syndrome with multiple lentigines (NSML) patient carrying a p.Q510P mutation in the PTPN11 gene. Stem cell research. 2019 Jan;34:101374.
Brodehl A et al. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies. International journal of molecular sciences. 2019 Sep 6;20(18).
Gripp KW et al. The sixth international RASopathies symposium: Precision medicine-From promise to practice. American journal of medical genetics. Part A. 2020 Mar;182(3):597-606.
Panda A et al. Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy. Differentiation; research in biological diversity. 2020 Mar-Apr;112:58-66.
Liu WS et al. Investigating the reason for loss-of-function of Src homology 2 domain-containing protein tyrosine phosphatase 2 (SHP2) caused by Y279C mutation through molecular dynamics simulation. Journal of biomolecular structure & dynamics. 2020 Jun;38(9):2509-2520.
Bekhite MM et al. Human Induced Pluripotent Stem Cell as a Disease Modeling and Drug Development Platform-A Cardiac Perspective. Cells. 2021 Dec 9;10(12).
Ercan-Sencicek A. Gulhan et al. Induced pluripotent stem cells for modeling Noonan, Noonan Syndrome with Multiple Lentigines, and Costello Syndromes. Current Progress in iPSC Disease Modeling. 2022-00-00.
Solman M et al. Modeling (not so) rare developmental disorders associated with mutations in the protein-tyrosine phosphatase SHP2. Frontiers in cell and developmental biology. 2022;10:1046415.
Bajia D et al. Effects of Noonan Syndrome-Germline Mutations on Mitochondria and Energy Metabolism. Cells. 2022 Oct 1;11(19).
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.